Page last updated: 2024-08-17

levodopa and Vascular Diseases

levodopa has been researched along with Vascular Diseases in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	1 (16.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, B; Chen, Y; Hou, Y; Liu, H; Ou, R; Shang, H; Song, W; Wei, Q; Yuan, X; Zhang, L	1
Gooneratne, IK; Udagedara, TB	1
Girotti, F; Musicco, M; Ronchetti, G; Scigliano, G	2
Fowler, B; Kuhn, W; Müller, T; Werne, B	1
Kamenetskiĭ, VK	1

Trials

2 trial(s) available for levodopa and Vascular Diseases

Article	Year
Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease. Parkinsonism & related disorders, 2009, Volume: 15, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Cholesterol; Dopamine Agents; Female; Humans; Levodopa; Lipids; Male; Middle Aged; Odds Ratio; Parkinson Disease; Retrospective Studies; Risk; Sympathetic Nervous System; Triglycerides; Vascular Diseases	2009
Levodopa reduces risk factors for vascular disease in parkinsonian patients. Journal of neurology, 2008, Volume: 255, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Blood Glucose; Blood Pressure; Cholesterol; Female; Humans; Levodopa; Lipid Metabolism; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Risk Factors; Vascular Diseases	2008

Article

Year

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease.

Parkinsonism & related disorders, 2009, Volume: 15, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Cholesterol; Dopamine Agents; Female; Humans; Levodopa; Lipids; Male; Middle Aged; Odds Ratio; Parkinson Disease; Retrospective Studies; Risk; Sympathetic Nervous System; Triglycerides; Vascular Diseases

2009

Levodopa reduces risk factors for vascular disease in parkinsonian patients.

Journal of neurology, 2008, Volume: 255, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Blood Glucose; Blood Pressure; Cholesterol; Female; Humans; Levodopa; Lipid Metabolism; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Risk Factors; Vascular Diseases

2008

Other Studies

4 other study(ies) available for levodopa and Vascular Diseases

Article	Year
Vascular risk factors and depression in Parkinson's disease. European journal of neurology, 2018, Volume: 25, Issue:4 Topics: Aged; Alcohol Drinking; Antiparkinson Agents; Anxiety; Asian People; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obesity; Overweight; Parkinson Disease; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Vascular Diseases	2018
Jaw tremor: a manifestation of vascular parkinsonism? - a case report. BMC neurology, 2018, Jun-30, Volume: 18, Issue:1 Topics: Aged; Brain; Female; Humans; Levodopa; Parkinsonian Disorders; Tremor; Vascular Diseases	2018
Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet (London, England), 1999, Jul-10, Volume: 354, Issue:9173 Topics: Aged; Antiparkinson Agents; Carboxy-Lyases; Female; Homocysteine; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Vascular Diseases	1999
[Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism]. Klinicheskaia meditsina, 1978, Volume: 56, Issue:9 Topics: Aged; Benactyzine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Vascular Diseases	1978